Left ventricular assist device: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Bruce M. Tindall
mNo edit summary
imported>James Yolkowski
m (fmt,wfy)
Line 1: Line 1:
{{subpages}}
{{subpages}}
Left Ventricular Assist Device or LVAD
A '''Left Ventricular Assist Device''' or '''LVAD''' is a [[pump]] which runs in parallel with a [[heart]] to boost the blood flow. The main reason for a patient to have a LVAD implanted is for [[Bridge To Transplant]] (BTT) or [[Destination Therapy]] (DT). Currently, the top three companies in this field are:
 
#[[Thoratec]] - Heartmate2 market capital $2B US
A Left Ventricular Assist Device is a pump which runs in parallel with a heart to boost the blood flow. The main reason for a patient to have a LVAD implanted is for Bridge To Transplant (BTT) or Destination Therapy (DT). Currently, the top three companies in this field are:
#[[Ventracor]] - VentrAssist
1. Thoratec - Heartmate2 market capital $2B US
#[[Heartware]]
2. Ventracor - VentrAssist
3. Heartware

Revision as of 20:33, 26 August 2009

This article is a stub and thus not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Left_ventricular_assist_device&printable=yes
This editable Main Article is under development and subject to a disclaimer.

A Left Ventricular Assist Device or LVAD is a pump which runs in parallel with a heart to boost the blood flow. The main reason for a patient to have a LVAD implanted is for Bridge To Transplant (BTT) or Destination Therapy (DT). Currently, the top three companies in this field are:

  1. Thoratec - Heartmate2 market capital $2B US
  2. Ventracor - VentrAssist
  3. Heartware
Retrieved from "https://citizendium.org/wiki/index.php?title=Left_ventricular_assist_device&oldid=571331"